RCP is focused on optimizing commercialization for clinical-stage biotechnology companies to prepare for future commercial success by building the foundation necessary for growth. At a time when investment in a full commercial team may be minimal or premature, RCP operates as an integrated, but fractional extension of our client partners providing comprehensive, cross-functional commercial expertise and execution to build the commercial foundation, address observable inefficiency and bring needed therapies to patients faster and with improved fiscal responsibility.